Literature DB >> 31995113

Large left ventricular non-infectious vegetation in patient with eosinophilic granulomatosis with polyangiitis.

Yun-Seok Song1, Sang-Hoon Seol2, Jino Park1, Dong-Kie Kim1, Yeo-Jeong Song1, Seunghwan Kim1, Ki-Hun Kim1, Doo-Il Kim1, Chan-Seon Park1, Yeon-Mi Kim3.   

Abstract

Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare form of systemic vasculitis in which cardiac involvement is relatively common and accounts for half of EGPA-related deaths. Cardiac involvement is more frequent in patients with an absence of anti-neutrophil cytoplasmic antibody and those with higher eosinophil counts. Clinical manifestations are various, including myocarditis, pericarditis, pericardial effusion, heart failure, arrhythmias, valvular insufficiencies and intra-cardiac thrombus formation. The pathology of cardiac involvement in EGPA is usually endomyocardial and pericardial eosinophilic infiltration. Considering the potentially adverse outcomes associated with cardiac involvement in EGPA, early detection is important. We experienced a rare case of EGPA with cardiac involvement presenting with non-infectious vegetations.

Entities:  

Keywords:  eosinophilic granulomatosis with polyangiitis (EGPA); left ventricular non‐infectious vegetation

Mesh:

Substances:

Year:  2020        PMID: 31995113      PMCID: PMC8762761          DOI: 10.5830/CVJA-2019-065

Source DB:  PubMed          Journal:  Cardiovasc J Afr        ISSN: 1015-9657            Impact factor:   1.167


  13 in total

1.  Effect of exercise on frequency of stent fracture in the superficial femoral artery.

Authors:  Osamu Iida; Shinsuke Nanto; Masaaki Uematsu; Takakazu Morozumi; Jun-ichi Kotani; Masaki Awata; Toshinari Onishi; Noriaki Ito; Fusako Sera; Hitoshi Minamiguchi; Hirokuni Akahori; Seiki Nagata
Journal:  Am J Cardiol       Date:  2006-06-06       Impact factor: 2.778

2.  SUPERB final 3-year outcomes using interwoven nitinol biomimetic supera stent.

Authors:  Lawrence A Garcia; Kenneth R Rosenfield; Christopher D Metzger; Frank Zidar; Ashish Pershad; Jeffrey J Popma; Margo Zaugg; Michael R Jaff
Journal:  Catheter Cardiovasc Interv       Date:  2017-05-04       Impact factor: 2.692

3.  Wire-Interwoven Nitinol Stent Outcome in the Superficial Femoral and Proximal Popliteal Arteries: Twelve-Month Results of the SUPERB Trial.

Authors:  Lawrence Garcia; Michael R Jaff; Christopher Metzger; Gino Sedillo; Ashish Pershad; Frank Zidar; Raghotham Patlola; Robert G Wilkins; Andrey Espinoza; Ayman Iskander; George S Khammar; Yazan Khatib; Robert Beasley; Satyaprakash Makam; Richard Kovach; Suraj Kamat; Luis R Leon; William Britton Eaves; Jeffrey J Popma; Laura Mauri; Dennis Donohoe; Carol C Base; Kenneth Rosenfield
Journal:  Circ Cardiovasc Interv       Date:  2015-05       Impact factor: 6.546

4.  Endovascular Treatment of Popliteal Artery Occlusion Caused by a Ruptured Supera Interwoven Nitinol Stent.

Authors:  Enrique M San Norberto; Liliana A Fidalgo-Domingos; Irene García-Saiz; James Taylor; Carlos Vaquero
Journal:  Ann Vasc Surg       Date:  2019-05-07       Impact factor: 1.466

5.  Fracture of a Supera Interwoven Nitinol Stent After Treatment of Popliteal Artery Stenosis.

Authors:  Tommaso Cambiaghi; Andrea Spertino; Luca Bertoglio; Roberto Chiesa
Journal:  J Endovasc Ther       Date:  2017-03-16       Impact factor: 3.487

6.  Preliminary results of the initial United States experience with the Supera woven nitinol stent in the popliteal artery.

Authors:  Luis R León; Robert S Dieter; Crystal L Gadd; Erika Ranellone; Joseph L Mills; Miguel F Montero-Baker; Angelika C Gruessner; John P Pacanowski
Journal:  J Vasc Surg       Date:  2013-04       Impact factor: 4.268

7.  Analysis of endovascular therapy for femoropopliteal disease with the Supera stent.

Authors:  Miguel Montero-Baker; Gregory J Ziomek; Luis Leon; Aaron Gonzales; Robert S Dieter; Crystal L Gadd; John P Pacanowski
Journal:  J Vasc Surg       Date:  2016-07-18       Impact factor: 4.268

8.  Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study.

Authors:  Marc Bosiers; Giovanni Torsello; Hans-Martin Gissler; Johannes Ruef; Stefan Müller-Hülsbeck; Thomas Jahnke; Patrick Peeters; Kim Daenens; Johannes Lammer; Herman Schroë; Klaus Mathias; Renate Koppensteiner; Frank Vermassen; Dierk Scheinert
Journal:  J Endovasc Ther       Date:  2009-06       Impact factor: 3.487

Review 9.  The incidence of arterial stent fractures with exclusion of coronary, aortic, and non-arterial settings.

Authors:  J Rits; J A van Herwaarden; A K Jahrome; D Krievins; F L Moll
Journal:  Eur J Vasc Endovasc Surg       Date:  2008-07-07       Impact factor: 7.069

Review 10.  Supera self-expanding stents for endovascular treatment of femoropopliteal disease: a review of the clinical evidence.

Authors:  Kalkidan Bishu; Ehrin J Armstrong
Journal:  Vasc Health Risk Manag       Date:  2015-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.